4 ms·
But some of those companies were breaking the rules that matter. Being 23andMe selling accurate genetic information to their customers outside the purview of t
by cowsandmilk 10y ago
But some of those companies were breaking the rules that matter.
Being 23andMe selling accurate genetic information to their customers outside the purview of the FDA is being naughty. They could do it because the science was there.
In the case of Theranos, selling diagnostics that don't work is not being naughty. It isn't evading useless regulation. It is selling pseudoscience.
Unfortunately, many investors and the business press cannot tell the difference.
- neurotech1 10y agoAgreed. 23AndMe side-stepped FDA red tape. The thing that annoys me with Theranos was they could have found scientifically justified ways of significantly improving diagnostic efficiency but chose not to. Other startups are working on low-cost methods of providing lab tests in developing areas, without the pseudoscience.
- deleted 10y ago[deleted]
- dredmorbius 10y agos/pseudoscience/fraud/